| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/05/1993 | US5250293 Method for the treatment of hypersensitivity diseases by administration of anionic polymers |
| 10/05/1993 | US5250286 For administering alpha-adrenergic blocking agent by inhalation |
| 10/05/1993 | US5250236 Method for producing solid lipid microspheres having a narrow size distribution |
| 10/05/1993 | US5250023 Transdermal administration method of protein or peptide drug and its administration device thereof |
| 10/05/1993 | US5250022 Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose |
| 10/05/1993 | CA1322722C Use of vinyl alcohol homopolymer and copolymers for tableting active materials |
| 10/05/1993 | CA1322717C Combination of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents and methods for treating diseases |
| 10/04/1993 | CA2093262A1 Anti-skin rash preparation |
| 10/01/1993 | CA2092861A1 Transdermal compositions |
| 09/30/1993 | WO1993019183A1 Immunization by inoculatioon of dna transcription unit |
| 09/30/1993 | WO1993019162A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 09/30/1993 | WO1993019154A1 NEUTRAL pH CLEANSING BAR |
| 09/30/1993 | WO1993019095A1 Cross-linked polysaccharides, a method of making them and their use |
| 09/30/1993 | WO1993018852A1 Oil-in-water emulsions of positively charged particles |
| 09/30/1993 | WO1993018785A1 Novel medicament |
| 09/30/1993 | WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders |
| 09/30/1993 | WO1993018774A1 Use if estriol for treating climacteric osteoporosis |
| 09/30/1993 | WO1993018762A2 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
| 09/30/1993 | WO1993018760A1 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 09/30/1993 | WO1993018758A1 Sustained release composition and method utilizing xanthan gum and an active ingredient |
| 09/30/1993 | WO1993018756A1 Anion exchange resin compositions |
| 09/30/1993 | WO1993018755A1 Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| 09/30/1993 | WO1993018754A1 Self-assembling diketopiperazine drug delivery system |
| 09/30/1993 | WO1993018753A1 Process for the preparation of sustained release pellets |
| 09/30/1993 | WO1993018752A1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 09/30/1993 | WO1993018751A1 Liposome encapsulated taxol and a method of using the same |
| 09/30/1993 | WO1993018750A1 Method for reducing side-effects of a drug |
| 09/30/1993 | WO1993018748A1 Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid |
| 09/30/1993 | WO1993018747A1 Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| 09/30/1993 | WO1993018746A1 Pressurized gas packagings using polyoxyethylene glyceryl-obates |
| 09/30/1993 | WO1993018649A1 Graft copolymers of polycationic species and water-soluble polymers, and uses thereof |
| 09/30/1993 | WO1993017040A3 Cystic fibrosis transmembrane conductance regulator (cftr) protein |
| 09/30/1993 | DE4309168A1 Powdery starting materials for coating solns. for pharmaceuticals - contain hydroxy propyl-methyl-cellulose or methyl cellulose of a specific particle size range |
| 09/30/1993 | DE4209160A1 Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung Cross-linked polysaccharides, process for their preparation and their use |
| 09/30/1993 | CA2590810A1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 09/30/1993 | CA2132327A1 Crosslinked polysaccharides, process for their preparation and their use |
| 09/30/1993 | CA2132102A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
| 09/30/1993 | CA2131790A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 09/30/1993 | CA2124353A1 Sustained release composition and method utilizing xanthan gum and an active ingredient |
| 09/29/1993 | EP0563024A1 Percutaneous salve preparation in the form of an adhesive tape |
| 09/29/1993 | EP0563013A2 N-substituted chitosane derivatives, process for preparing them and their use |
| 09/29/1993 | EP0562863A1 Protein stabilised oil-in-water emulsions |
| 09/29/1993 | EP0562641A1 Dehydrated liposomes |
| 09/29/1993 | EP0562445A2 Ophthalmic gel |
| 09/29/1993 | EP0562303A2 Chemical valve |
| 09/29/1993 | EP0562188A1 Composition for tissues to sustain viability and biological functions in surgery and storage |
| 09/29/1993 | EP0562125A1 Antibody composition |
| 09/29/1993 | EP0562041A1 Subsaturated transdermal drug delivery device exhibiting enhanced drug flux |
| 09/29/1993 | EP0562020A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 09/29/1993 | EP0561983A1 Systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers |
| 09/29/1993 | EP0561874A1 Non-aqueous microemulsion for drug delivery |
| 09/29/1993 | EP0561866A1 Lyophilized amino acid compositions containing glutamine. |
| 09/29/1993 | EP0553195A4 Biocompatible microcapsules |
| 09/29/1993 | EP0523150A4 Device and method for enhanced administration of physostigmine |
| 09/29/1993 | EP0428520B1 Antimicrobial composition with long-term activity |
| 09/29/1993 | EP0413034B1 Poultice and preparation thereof |
| 09/29/1993 | CN2142822Y Automatic cutting and packing machine for hard plaster |
| 09/29/1993 | CN1076623A Cactus preparation and its preparation method |
| 09/29/1993 | CN1076622A Blood-activating analgetic plaster for tumour |
| 09/29/1993 | CN1076615A Low side-effect compound gentamicin preparation |
| 09/29/1993 | CN1076614A Liposomal itraconazole formulations |
| 09/29/1993 | CN1076613A Elemene emulsion injection and its preparing process |
| 09/29/1993 | CN1022219C Technology and process for preparing travelling healthy medcine "Yongquangao" |
| 09/28/1993 | US5248772 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 09/28/1993 | US5248761 Amino acid terminated polyesters having predetermined monomeric sequence |
| 09/28/1993 | US5248700 Glycolic-lactic polylactone |
| 09/28/1993 | US5248676 Estradiol percutaneous administration preparations |
| 09/28/1993 | US5248674 Percutaneous administration of 3'-azide'-deoxythymidine |
| 09/28/1993 | US5248590 Surface modified liposomes |
| 09/28/1993 | US5248516 Freeze-drying, water dispersion, spraying |
| 09/28/1993 | US5248504 Method of treatment for nasal and sinus dysfunction |
| 09/28/1993 | US5248501 Plant extract for reducing irritation, dryness |
| 09/28/1993 | US5248493 Pharmaceutical composition |
| 09/28/1993 | US5248310 Oral osmotic device with hydrogel driving member |
| 09/28/1993 | CA2092513A1 N-substituted chitosan derivatives, process for their preparation and the use thereof |
| 09/28/1993 | CA1322529C Dosage form of fenofibrate |
| 09/24/1993 | WO1993018745A1 Use of antiviral coating for latex items such as condoms |
| 09/24/1993 | CA2108143A1 Use of an antiviral coating for latex viral barrier items such as condoms |
| 09/23/1993 | DE4305979A1 Chemical responsive valve used e.g. as release means for medicaments - has polymer matrix with variable permeability responding to ambient conditions |
| 09/23/1993 | DE4305079A1 Thioctic acid, mesna and flupirtin maleate solid forms |
| 09/23/1993 | DE4305078A1 Pharmaceutical compsns. for inhalation contg. flezelastin or salts |
| 09/23/1993 | DE4230876A1 Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten Aerosols under-use of polyoxyethylene glyceryl oleates |
| 09/23/1993 | DE4208527A1 Liposomen mit negativer ueberschussladung Liposomes with negative excess charge |
| 09/23/1993 | DE4208344A1 Application of active, protective or healing substance to skin - esp. to face and shoulders, by means of gaseous stream contg. oxygen |
| 09/23/1993 | DE4207922A1 New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water |
| 09/22/1993 | EP0561734A1 Oleaginous-containing matrix materials in edible protein compositions |
| 09/22/1993 | EP0561695A1 Bioadhesive opthalmic insert |
| 09/22/1993 | EP0561597A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them |
| 09/22/1993 | EP0561424A1 Dehydrated liposomes |
| 09/22/1993 | EP0561330A1 Topical insulin preparation |
| 09/22/1993 | EP0561166A1 Aerosol compositions containing compound D-18024 and its analogs |
| 09/22/1993 | EP0560937A1 Pharmaceutical compositions |
| 09/22/1993 | EP0560900A1 Prevention of synovial adhesions. |
| 09/22/1993 | EP0560821A1 Solid dosage forms of almokalant and processes for manufacture thereof |
| 09/22/1993 | EP0560816A1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
| 09/22/1993 | EP0560809A1 Agent for reducing the growth of, or removing, human body hair. |
| 09/22/1993 | EP0560805A1 Iontotherapeutic devices, reservoir electrode devices therefor, process and unit dose |
| 09/22/1993 | EP0526578A4 Composition and method for topical treatment of damaged or diseased tissue |
| 09/22/1993 | EP0479781B1 Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome |
| 09/22/1993 | EP0464106A4 Device for administering an active agent to the skin or mucosa |